Our New Bureau – Mumbai
Onco Therapies, a wholly-owned subsidiary of Strides Arcolab, has received US FDA approvals for methotrexate injection USP 25 mg/ mL packaged in 1 gram/ 40 m, 50 mg/2 mL, 100 mg / 4 mL, 200 mg/ 8 mL and 250 mg / 10 mL Single dose vials.
Methotrexate is amongst the products in the drug shortage list of US FDA. According to IMS data, the US market for generic methotrexate is approximately $ 13 Million.
Methotrexate is part of the oncology portfolio licensed to Pfizer in January 2010 for the US market and expected to be launched shortly.